|
||||||
| July 2007 | ||||||
 |
  The
New Global Marketplace:Expanded Opportunities With the “E7” Countries Likely, you are familiar with the “G5” countries (the United Kingdom, France, Germany, Italy and Spain), which as a block make up a significant percentage of most pharmaceutical product markets – United States and Japan aside – and thus are appropriately included in the majority of global pharmaceutical marketing research projects conducted at the present time. But do you know what the “E7” countries are? If not, you should become familiar with them. According to a recently published PricewaterhouseCoopers report, the global pharmaceutical market will double in value to $1.3 trillion by 2020 with the “E7” countries collectively accounting for up to 20 percent of this newly enlarged market, up 60 percent from 2004. In this month’s published document for The Orange Pages, we look first at the way “global” marketing research is approached today, reflecting in brief on its sophistication over past decades when conducting “international” research meant simply translating the English version of the questionnaire into the local language. Second, we define and discuss the three major dimensions that must be considered for each country in the conduct of these increasingly complex global projects: medical and reimbursement systems, treatment practices and the logistics of planning and conducting the research itself. Finally, we look ahead to the future of the global arena, examining the predictions made in the recent PricewaterhouseCoopers report. What are the challenges and impacts of expanding the global pharmaceutical market to include the opportunities in “E7” countries? What recommendations will help pharmaceutical marketing researchers and top decision makers prepare for this “brave new world”? To download the complete July 2007 discussion on the changing environment of global marketing research, please click here.  Are
You Receiving The Orange Pages?
The monthly issue-based discussions that we publish in this newsletter can also be distributed to you in hardcopy format via a complimentary subscription-based resource we publish for our clients called The Orange Pages. The Orange Pages is intended to serve as a living, breathing resource of “Information, Education and Issues Exploration for Today’s Pharmaceutical Marketing Researcher” that we hope will be read with interest and kept within reach for ongoing reference. The format is a handy sized three-ring binder designed to hold packets of content that we will develop and distribute on a variety of topics. Content packets will come to you in an easy to identify (and appropriately colored) orange envelope and be delivered on a monthly basis. The materials will be three-hole punched for convenient one-click assembly into your binder.  If you would like to receive a complimentary copy of The Orange Pages binder, and get on our distribution list for monthly addendums, please fill out the form below. Want to learn more on this topic? Please contact:  |
|
||||
        |
||||||
   |
||||||
